Menopause and Shortsightedness - from FDA reports
Shortsightedness is reported only by a few people with Menopause. We study 1 people who have Shortsightedness and Menopause from FDA . Find out below who they are, other conditions they have and drugs they take.
What to expect?
You are not alone!
Personalized health information
On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>
On Nov, 20, 2017
1 person who has Menopause and Shortsightedness is studied.
Number of reports submitted per year:
Age of people who have Menopause and experience Shortsightedness *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 100 %
- 50-59: 0.0 %
- 60+: 0.0 %
Top co-existing conditions for these people *:
- Sleep Disorder (1 person, 100.00%)
- Rheumatoid Arthritis (1 person, 100.00%)
- Neuralgia (1 person, 100.00%)
- Muscle Relaxant Therapy (1 person, 100.00%)
- Hypothyroidism (1 person, 100.00%)
Most common drugs for these people *:
- Xeljanz Xr (1 person, 100.00%)
- Lyrica (1 person, 100.00%)
Top symptoms for these people *:
- Speech Disorder (1 person, 100.00%)
- Memory Loss (1 person, 100.00%)
- Fall (1 person, 100.00%)
- Balance Disorder (1 person, 100.00%)
- Abnormal Behavior (1 person, 100.00%)
* Approximation only. Some reports may have incomplete information.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Subscribe to the study: get notified of updates to the study.
Do you have Shortsightedness and Menopause?
- Check symptoms - is your shortsightedness caused by a drug or a condition?
- Get alerts to symptoms - forecast your symptoms and get alerts
- Join related support groups - you are not alone, join a support group on ehealth.me
- Report the side effect - help people in need and in real time
- Ask a question - ask a question related to the study
- Write a Post - share your experience related to the study
- More tools...
Expand the study to include reports from both FDA and eHealthMeShortsightedness and Menopause from FDA and eHealthMe reports
Menopause (end of monthly cycles in women) can be treated by Estradiol, Premarin, Progesterone, Prempro, Prometrium (latest reports from 7,573 Menopause patients)
Shortsightedness (unable to see distance object) has been reported by people with migraine, multiple sclerosis, depression, high blood pressure, osteoporosis (latest reports from 1,816 Shortsightedness patients).